Literature DB >> 19047643

Growth of uterine leiomyomata among premenopausal black and white women.

Shyamal D Peddada1, Shannon K Laughlin, Kelly Miner, Jean-Philippe Guyon, Karen Haneke, Heather L Vahdat, Richard C Semelka, Ania Kowalik, Diane Armao, Barbara Davis, Donna Day Baird.   

Abstract

Uterine leiomyomata (fibroids) are the leading cause of hysterectomy in the United States. Black women have a greater fibroid burden than whites, yet no study has systematically evaluated the growth of fibroids in blacks and whites. We prospectively tracked growth for 262 fibroids (size range: 1-13 cm in diameter) from 72 premenopausal participants (38 blacks and 34 whites). Fibroid volume was measured by computerized analysis of up to four MRI scans over 12 months. We used mixed effects models to identify factors that are associated with growth, and results were converted to percent change per 6 months for clinical relevance. The median growth rate was 9% (range: -89% to +138%). Seven percent of fibroids regressed (>20% shrinkage). Tumors from the same woman grew at different rates (within-woman component of variation was twice the component among women; both were significant, P < 0.001). Black and white women less than 35 years of age had similar fibroid growth rates. However, growth rates declined with age for whites but not for blacks (P = 0.05). The odds of a tumor growing more than 20% in 6 months also decreased with age for whites but not for blacks (P < 0.01). Growth rates were not influenced by tumor size, location, body mass index, or parity. We conclude that (i) spontaneous regression of fibroids occurs; (ii) fibroids from the same woman grow at different rates, despite a uniform hormonal milieu; (iii) fibroid size does not predict growth rate; and (iv) age-related differences in fibroid growth between blacks and whites may contribute to the higher symptom burden for black women.

Entities:  

Mesh:

Year:  2008        PMID: 19047643      PMCID: PMC2604959          DOI: 10.1073/pnas.0808188105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  Uterine myomas: an overview of development, clinical features, and management.

Authors:  Edward E Wallach; Nikos F Vlahos
Journal:  Obstet Gynecol       Date:  2004-08       Impact factor: 7.661

2.  The frequency of uterine leiomyomas.

Authors:  S F Cramer; A Patel
Journal:  Am J Clin Pathol       Date:  1990-10       Impact factor: 2.493

3.  Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth.

Authors:  Małgorzata Wolańska; Edward Bańkowski
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2006-03-24       Impact factor: 2.435

Review 4.  Uterine fibroids.

Authors:  E A Stewart
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

5.  Natural history of uterine polyps and leiomyomata.

Authors:  Deborah J DeWaay; Craig H Syrop; Ingrid E Nygaard; William A Davis; Bradley J Van Voorhis
Journal:  Obstet Gynecol       Date:  2002-07       Impact factor: 7.661

6.  Risk factors for uterine fibroids: reduced risk associated with oral contraceptives.

Authors:  R K Ross; M C Pike; M P Vessey; D Bull; D Yeates; J T Casagrande
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-09

7.  Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene.

Authors:  K Hashimoto; C Azuma; S Kamiura; T Kimura; T Nobunaga; T Kanai; M Sawada; S Noguchi; F Saji
Journal:  Gynecol Obstet Invest       Date:  1995       Impact factor: 2.031

8.  High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.

Authors:  Donna Day Baird; David B Dunson; Michael C Hill; Deborah Cousins; Joel M Schectman
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

9.  Self-reported heavy bleeding associated with uterine leiomyomata.

Authors:  Ganesa Wegienka; Donna Day Baird; Irva Hertz-Picciotto; Siobán D Harlow; John F Steege; Michael C Hill; Joel M Schectman; Katherine E Hartmann
Journal:  Obstet Gynecol       Date:  2003-03       Impact factor: 7.661

10.  Triple-phase dynamic MRI of intratumoral vessel density and hyalinization grade in uterine leiomyomas.

Authors:  Ken Shimada; Isamu Ohashi; Ichiro Kasahara; Naoyuki Miyasaka; Hitoshi Shibuya
Journal:  AJR Am J Roentgenol       Date:  2004-04       Impact factor: 3.959

View more
  100 in total

1.  Pregnancy-related fibroid reduction.

Authors:  Shannon K Laughlin; Amy H Herring; David A Savitz; Andrew F Olshan; Julia R Fielding; Katherine E Hartmann; Donna D Baird
Journal:  Fertil Steril       Date:  2010-05-07       Impact factor: 7.329

2.  Self-report versus ultrasound measurement of uterine fibroid status.

Authors:  Sharon L Myers; Donna Day Baird; Andrew F Olshan; Amy H Herring; Jane C Schroeder; Leena A Nylander-French; Katherine E Hartmann
Journal:  J Womens Health (Larchmt)       Date:  2011-11-01       Impact factor: 2.681

Review 3.  Estrogen receptors and human disease: an update.

Authors:  Katherine A Burns; Kenneth S Korach
Journal:  Arch Toxicol       Date:  2012-05-31       Impact factor: 5.153

4.  Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations.

Authors:  Jia Xie; Julianne Ubango; Yanli Ban; Debabrata Chakravarti; J Julie Kim; Jian-Jun Wei
Journal:  Genes Chromosomes Cancer       Date:  2018-08-20       Impact factor: 5.006

5.  Laparoscopic ultrasound procedure can reduce residual myomas in laparoscopic myomectomy for multiple myomas.

Authors:  Takashi Mimura; Junichi Hasegawa; Tetsuya Ishikawa; Akihiko Sekizawa
Journal:  J Med Ultrason (2001)       Date:  2016-05-09       Impact factor: 1.314

6.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

7.  Injectable Clostridium histolyticum collagenase as a potential treatment for uterine fibroids.

Authors:  Lisa N Brunengraber; Friederike L Jayes; Phyllis C Leppert
Journal:  Reprod Sci       Date:  2014-10-20       Impact factor: 3.060

Review 8.  The role of progesterone signaling in the pathogenesis of uterine leiomyoma.

Authors:  J Julie Kim; Elizabeth C Sefton
Journal:  Mol Cell Endocrinol       Date:  2011-06-06       Impact factor: 4.102

9.  Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy.

Authors:  F A Taran; E A Stewart; S Brucker
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

10.  Trends in the national distribution of laparoscopic hysterectomies from 2003 to 2010.

Authors:  Jinhyung Lee; Kristofer Jennings; Mostafa A Borahay; Ana M Rodriguez; Gokhan S Kilic; Russell R Snyder; Pooja R Patel
Journal:  J Minim Invasive Gynecol       Date:  2014-01-24       Impact factor: 4.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.